Cargando…

Combinatorial therapeutic approaches of photodynamic therapy and immune checkpoint blockade for colon cancer treatment

Photodynamic therapy (PDT) has shown impressive therapeutic effects on various types of cancers by reactive oxygen species (ROS) generation and induction of immune responses. However, under certain conditions, the immune responses induced by PDT are not always sufficient to eradicate the remaining t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Yang, Chung, Chih Kit, Gu, Zili, Schomann, Timo, Dong, Xiaoxu, Veld, Ruben V. Huis in ‘t, Camps, Marcel G. M., ten Dijke, Peter, Ossendorp, Ferry A., Cruz, Luis J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381671/ https://www.ncbi.nlm.nih.gov/pubmed/35974207 http://dx.doi.org/10.1186/s43556-022-00086-z

Ejemplares similares

Combinatorial Therapeutic Approaches with Nanomaterial-Based Photodynamic Cancer Therapy
por: Hao, Yang, et al.
Publicado: (2022)

M1-derived extracellular vesicles enhance photodynamic therapy and promote immunological memory in preclinical models of colon cancer
por: Huis in ‘t Veld, Ruben V., et al.
Publicado: (2022)

Combined Inhibition of TGF-β Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models
por: Sow, Heng Sheng, et al.
Publicado: (2019)

Zinc-Phthalocyanine-Loaded Extracellular Vesicles Increase Efficacy and Selectivity of Photodynamic Therapy in Co-Culture and Preclinical Models of Colon Cancer
por: Lara, Pablo, et al.
Publicado: (2021)

Current Challenges and Opportunities of Photodynamic Therapy against Cancer
por: Huis in ‘t Veld, Ruben V., et al.
Publicado: (2023)

Combining Photodynamic Therapy with Immunostimulatory Nanoparticles Elicits Effective Anti-Tumor Immune Responses in Preclinical Murine Models
por: Huis in ‘t Veld, Ruben Victor, et al.
Publicado: (2021)

Photodynamic Therapy in Combination with the Hepatitis B Core Virus-like Particles (HBc VLPs) to Prime Anticancer Immunity for Colorectal Cancer Treatment
por: Hao, Yang, et al.
Publicado: (2022)

Immune checkpoint inhibition combined with targeted therapy using a novel virus-like drug conjugate induces complete responses in a murine model of local and distant tumors
por: Huis in ‘t Veld, Ruben V., et al.
Publicado: (2023)

Combination of photodynamic therapy and stimulator of interferon genes (STING) agonist inhibits colorectal tumor growth and recurrence
por: Hao, Yang, et al.
Publicado: (2023)

Genome-wide CRISPR screens define determinants of epithelial-mesenchymal transition mediated immune evasion by pancreatic cancer cells
por: Gu, Yuanzhuo, et al.
Publicado: (2023)

In Vitro Testing of the Virus-Like Drug Conjugate Belzupacap Sarotalocan (AU-011) on Uveal Melanoma Suggests BAP1-Related Immunostimulatory Capacity
por: Ma, Sen, et al.
Publicado: (2023)

Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors
por: Roy, Dia, et al.
Publicado: (2023)

Bacterial Cellulose as Drug Delivery System for Optimizing Release of Immune Checkpoint Blocking Antibodies
por: Chung, Chih Kit, et al.
Publicado: (2022)

A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control
por: Tondini, Elena, et al.
Publicado: (2019)

Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments
por: Wang, Xueyan, et al.
Publicado: (2022)

Immune Checkpoint Therapy: Tumor Draining Lymph Nodes in the Spotlights
por: Fransen, Marieke F., et al.
Publicado: (2021)

Preclinical and Clinical Evidence of Immune Responses Triggered in Oncologic Photodynamic Therapy: Clinical Recommendations
por: Beltrán Hernández, Irati, et al.
Publicado: (2020)

Editorial: Combinatorial Approaches to Enhance Anti-tumor Immunity: Focus on Immune Checkpoint Blockade Therapy
por: Andersson, Patrik, et al.
Publicado: (2019)

Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors
por: Ossendorp, Ferry, et al.
Publicado: (1998)

Autophagy regulates long‐term cross‐presentation by murine dendritic cells
por: Ho, Nataschja I., et al.
Publicado: (2021)

PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors
por: Beyrend, Guillaume, et al.
Publicado: (2019)

OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum
por: van der Sluis, Tetje C., et al.
Publicado: (2023)

Sustained cross‐presentation capacity of murine splenic dendritic cell subsets in vivo
por: Ho, Nataschja I., et al.
Publicado: (2018)

The developing landscape of combinatorial therapies of immune checkpoint blockade with DNA damage repair inhibitors for the treatment of breast and ovarian cancers
por: Zhu, Lingling, et al.
Publicado: (2021)

Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy
por: He, Chunbai, et al.
Publicado: (2016)

Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma
por: Xu, Jianjun, et al.
Publicado: (2021)

MCT4 blockade increases the efficacy of immune checkpoint blockade
por: Babl, Nathalie, et al.
Publicado: (2023)

Differential Influence on Cytotoxic T Lymphocyte Epitope Presentation by Controlled Expression of Either Proteasome Immunosubunits or Pa28
por: van Hall, Thorbald, et al.
Publicado: (2000)

Combinatorial Strategies With PD-1/PD-L1 Immune Checkpoint Blockade for Breast Cancer Therapy: Mechanisms and Clinical Outcomes
por: Zheng, Dan, et al.
Publicado: (2022)

Pheophorbide A–Mediated Photodynamic Therapy Potentiates Checkpoint Blockade Therapy of Tumor with Low PD–L1 Expression
por: Tong, Qinli, et al.
Publicado: (2022)

Photodynamic therapy changes tumour immunogenicity and promotes immune-checkpoint blockade response, particularly when combined with micromechanical priming
por: Lobo, Catarina S., et al.
Publicado: (2023)

PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy
por: Kleinovink, Jan Willem, et al.
Publicado: (2017)

Corticosteroids and immune checkpoint blockade
por: Min, Le, et al.
Publicado: (2015)

Immune checkpoint blockade in HIV
por: Gubser, Celine, et al.
Publicado: (2022)

Antimicrobial Photodynamic Therapy: Latest Developments with a Focus on Combinatory Strategies
por: Youf, Raphaëlle, et al.
Publicado: (2021)

Low-dose immunogenic chemotherapeutics promotes immune checkpoint blockade in microsatellite stability colon cancer
por: Fang, Yuhang, et al.
Publicado: (2022)

The structural flexibility of MAD1 facilitates the assembly of the Mitotic Checkpoint Complex
por: Chen, Chu, et al.
Publicado: (2023)

Cyclin B1 scaffolds MAD1 at the kinetochore corona to activate the mitotic checkpoint
por: Allan, Lindsey A, et al.
Publicado: (2020)

Enhanced cancer therapy through synergetic photodynamic/immune checkpoint blockade mediated by a liposomal conjugate comprised of porphyrin and IDO inhibitor
por: Huang, Zeqian, et al.
Publicado: (2019)

Drug-Loaded Photosensitizer-Chitosan Nanoparticles for Combinatorial Chemo- and Photodynamic-Therapy of Cancer
por: Pandya, Abhilash D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_28oahchjfmaekcm5accd5p2btq